Short Interest in CBD Life Sciences Inc. (OTCMKTS:CBDL) Decreases By 88.3%

CBD Life Sciences Inc. (OTCMKTS:CBDL) was the target of a large decline in short interest in the month of January. As of January 15th, there was short interest totalling 39,500 shares, a decline of 88.3% from the December 31st total of 338,600 shares. Based on an average trading volume of 75,074,700 shares, the days-to-cover ratio is presently 0.0 days.

CBD Life Sciences Price Performance

CBDL stock traded up $0.00 during midday trading on Tuesday, reaching $0.00. 78,543,588 shares of the company’s stock traded hands, compared to its average volume of 21,240,439. CBD Life Sciences has a 52 week low of $0.00 and a 52 week high of $0.03.

About CBD Life Sciences

CBD Life Sciences Inc engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.